The low dosage hydrate inhibitors market is anticipated to have a valuation of USD 81.57 billion in 2023. According to Future Market Insights, between 2023 and 2033, the market is forecast to expand at a 8% CAGR and reach a value of USD 176.82 billion.
By reducing delivery frequency and chemical usage, low dosage hydrate inhibitors can lower transportation and handling costs, which is expected to provide an absolute opportunity of USD 95.24 billion by 2033.
Due to the avoidance of gas hydrates, the demand for low dosage hydrate inhibitors is increasing in the oil and gas industry. When certain liquids, gasses, and water interact under specific pressure and temperature circumstances, hydrates are produced.
The formation or agglomeration of the gas hydrates results in a blockage that stops the flow of gas and oil through the pipeline.
Little consumer understanding of the uses and advantages of low dosage hydrate inhibitors, however, discourages consumer use and increases demand for alternatives like high throughput experimentation (HTE) and thermodynamic inhibitors. Thus, it is projected that this is likely to limit the market expansion.
Despite certain obstacles, the industry has some promising prospects, including an increasing number of offshore oil & gas operations, drilling exploration wells, and finding green hydrate inhibitors are anticipated to bolster the demand for these inhibitors.
| Attributes | Details |
|---|---|
| Low Dosage Hydrate Inhibitors Market CAGR (2023 to 2033) | 8% |
| Low Dosage Hydrate Inhibitors Market Size (2023) | USD 81.57 billion |
| Low Dosage Hydrate Inhibitors Market Size (2033) | USD 176.82 billion |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The low dosage hydrate inhibitors industry is expected to expand at a robust 8% CAGR between 2023 and 2033, up from 7.7% CAGR recorded during 2018 to 2022, predicts Future Market Insights (FMI).
| Particulars | Details |
|---|---|
| Jan to Jun (H1), 2021 (A) | 7.8% |
| Jan to Jun (H1), 2022 Projected (P) | 8.1% |
| Jan to Jun (H1), 2022 Outlook (O) | 7.6% |
| BPS: H1, 2022 (O) - H1, 2022 (P) | -50↓ |
| BPS: H1, 2021 (O) - H1, 2022 (A) | -20↓ |
Earlier, thermodynamic hydrate inhibitors (THIs) were used by the oil and gas industry due to their ability to shift the hydrate-equilibrium curve towards lower temperatures and higher pressures. These inhibitors were able to change the activity of water molecules to accelerate the shift.
However, a new group of chemicals called low dosage hydrate inhibitors was developed later, and they differed from THIs. Instead of shifting the hydrate curve, the new group interfered with the process of hydrate formation with the help of numerous mechanisms.
In addition to this, as the dosage requirement of these inhibitors was lower than that of THIs, these gained high popularity among customers. Moreover, low dosage hydrate inhibitors can extend the operating life of gas systems, and because of this advantage, their demand is likely to surge among crude oil product manufacturers worldwide.
Apart from that, increasing adoption of these inhibitors to introduce combination products is set to drive sales in the forthcoming years. Anti-agglomerant hydrate inhibitors are increasingly used and are well acknowledged as a crucial addition in the low dosage hydrate inhibitors market.
Due to its ability to improve hydrate management, the hybrid approach to hydrate inhibitors is growing in popularity in the oil and gas sector. As a result, the market has seen an increase in demand for anti-agglomerant Hydrate Inhibitors, and it is probable that it is likely to continue to play a significant role in this market going forward.
Principal Consultant
High Adoption of Anti-agglomerant Hydrate Inhibitors in Offshore Operations to Boost Growth.
Increasing number of offshore oil and gas operations is likely to propel the growth in the United Kingdom. Europe market is expected to account for 30.2% of the total market share in 2022, finds FMI.
Moreover, surging adoption of anti-agglomerant hydrate inhibitors in offshore operations is projected to boost the market in the United Kingdom. Increasing need for generator maintenance, especially in the gas and crude oil extraction industries, is likely to boost the market.
According to CEIC Data, in December 2020, crude oil production was reported at 930.536 barrels/day in the United Kingdom, while in December 2019, it was 1,007.195 barrels/day. This trend is expected to continue throughout the forecast period, thereby augmenting the growth in the United Kingdom market.
| United States Market Value (2033) | USD 25.49 billion |
|---|---|
| United States Market CAGR (2018 to 2022) | 7.5% |
| United States Market CAGR (2023 to 2033) | 8% |
The demand for low dosage hydrate inhibitors in the United States is primarily driven by the country's large oil and gas industry, which relies on pipelines and other equipment to transport hydrocarbons from production sites to refineries and processing facilities.
Due to this, the United States is likely to gain an absolute opportunity of USD 13.74 billion during the forecast period.
Also, in the LDHIs market, kinetic hydrate inhibitors are often used in combination with other types of inhibitors, including Anti-agglomerant Hydrate Inhibitors (AAHIs) and Anti-adhesion Hydrate Inhibitors (AAHIs), to create more effective hydrate inhibition programs.
Key Players are Preferring Hydrate Inhibitors for Drilling Exploration Wells
| China Market Value (2033) | USD 29.52 billion |
|---|---|
| China Market CAGR (2018 to 2022) | 8.2% |
| China Market CAGR (2023 to 2033) | 8.3% |
Rising production of natural gas in offshore areas is anticipated to fuel the growth in China during the forecast period, and expects an absolute opportunity of USD 16.23 billion. East Asia's low dosage hydrate inhibitors business is set to account for approximately 18.4% of the total market share in 2022, predicts FMI.
In January 2022, for instance, China National Offshore Oil Corporation (CNOOC) announced its plan to accelerate its oil and gas production in 2022 by 10%, compared to 2021’s goal. The company is aiming to drill 360 exploration wells and initiate 13 projects this year. Such innovative steps taken by key players in the country are expected to support the market.
Furthermore, China became the world’s leading Liquefied Natural Gas (LNG) importer in the first 10 months of 2021. Between January and October, the country’s LNG imports stood at 10.3 Bcf/d, which exhibited a 24% surge, as compared to the same period in 2020. The demand for LNG is anticipated to rise in this country, which, in turn, is likely to bolster the sales of low dosage hydrate inhibitors over the assessment period.
Researchers are Focusing on Finding Green Hydrate Inhibitors to Comply with Norms.
Increasing focus on environmental compliance in the oil & gas sector is set to bolster the demand for biodegradable materials in Canada. As per FMI, North America's low dosage hydrate inhibitors sector is anticipated to account for 16.0% of share in 2022.
In addition to that, thermodynamic hydrate inhibitors are being substituted with green alternatives, as these require high dosage rates. Many educational institutions in Canada are also conducting extensive research and development activities to come up with eco-friendly alternatives.
As per a study published in the National Center for Biotechnology Information (NCBI), researchers at the Queen's University found that antifreeze proteins have the ability to transform the structure II tetrahydrofuran hydrate crystal morphologies.
They are superior hydrate inhibitors than the kinetic inhibitor called poly-N-vinylpyrrolidone. Also, these proteins can be used to create biologically based hydrate inhibitors in the future. Backed by these factors, demand is expected to gain momentum in Canada over the forecast period.
By 2033, Germany's market value is anticipated to be USD 2,237.2 million. The expected increase is from 5% CAGR from 2018 to 2022 to 5.3% from 2023 to 2033.
Germany has an oil and gas sector, but it is not as developed as in some other nations, and the country's emphasis on renewable energy sources may restrain the expansion of the LDHIs market there.
Even while the LDHIs market in Germany might not expand as quickly as in some other nations, it is nevertheless anticipated to profit from these more general trends. The emphasis on renewable energy sources may potentially increase adoption of low dosage hydrate inhibitors in other fields, such as the transportation and storage of hydrogen, which is more and more considered a viable alternative for fossil fuels.
| Segment | Product Type |
|---|---|
| Top-segment | Kinetic Hydrate Inhibitors |
| CAGR (2018 to 2022) | 5.8% |
| CAGR (2023 to 2033) | 6.2% |
| Segment | Terrain Type |
|---|---|
| Top-segment | Offshore |
| CAGR (2018 to 2022) | 7.6% |
| CAGR (2023 to 2033) | 8% |
By product type, the kinetic hydrate inhibitors segment is expected to dominate the low dosage hydrate inhibitors sector in the forthcoming years. Growth is attributable to their high compatibility, relatively lower transportation costs, and reduced capital costs.
AA inhibitors are expected to have a high scope in the market, as they are specially designed to keep hydrates dispersed in condensate or oil, and thus the hydrates separate very slowly from the hydrocarbon liquid. Also, in the presence of a liquid hydrocarbon phase acting as the hydrate crystals carrier, these inhibitors deliver optimal performance, which is expected to boost sales.
Oil and Gas Industry is Utilizing Inhibitors in Offshore Operations to Reduce Capital Expenses.
Based on terrain type, the offshore segment is projected to remain at the forefront in the low dosage hydrate inhibitors market in terms of share. These inhibitors can reduce the capital expenses in the offshore oil and gas industry by lowering the injection-rate and chemical-storage requirements.
Furthermore, these often eliminate the need for regeneration, as the chemicals are not easily recoverable. This plays a significant role in offshore operations, where desk space and payload are critical.
They also help in boosting the production rates whenever the flow line or inhibitor-injection capacity is limited. The beneficial properties of low dosage hydrate inhibitors are anticipated to bolster their demand in the offshore terrain.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Methane hydrate inhibitors (MHIs) are now being produced and developed by a number of industries for usage in the oil and gas sector. These producers are aiming to create brand-new, cutting-edge MHIs that are more efficient, effective, and eco-friendly.
As an illustration, Schlumberger Ltd is a well-known supplier of technology, services, and solutions to the oil and gas sector. Under its Clariant Oil Services brand, the company provides a variety of MHIs, including the Hydrate Inhibitor EHP and the Hydrate Inhibitor SRP.
Leading players operating in the low dosage hydrate inhibitors market are focusing partnerships with oil and gas companies to conduct exhaustive research and development activities.
They are doing so to come up with state-of-the-art solutions that are able to serve numerous purposes at once. Other players are engaging in acquisitions, collaborations, joint ventures, and capacity expansions to gain a strong foothold in this market.
This market is estimated to reach USD 176.82 billion by 2033.
High adoption of anti-agglomerate hydrate inhibitors boosts market growth in the United Kingdom.
Consumer unawareness restricts market growth.
Rising offshore activities and eco-friendly hydrate inhibitors drive demand.
The United Kingdom holds a substantial share of the market.
1. Executive Summary 2. Market Overview 3. Key Market Trends 4. Key Success Factors 5. Market Background 6. Global Market Demand Analysis 2018 to 2022 and Forecast, 2023 to 2033 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, by Product Type 7.1. Anti-Agglomerate (AA) inhibitors 7.2. Kinetic Hydrate Inhibitors (KHI) 8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, by Terrain Type 8.1. Onshore 8.2. Offshore 9. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, by Region 9.1. North America 9.2. Latin America 9.3. Europe 9.4. East Asia 9.5. South Asia 9.6. Oceania 9.7. Middle East and Africa (MEA) 10. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033 11. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033 12. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033 13. South Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033 14. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033 15. Oceania Market Analysis 2018 to 2022 and Forecast 2023 to 2033 16. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033 18. Market Structure Analysis 19. Competition Analysis 19.1. BASF SE 19.2. Schlumberger Limited 19.3. Arkema Group 19.4. Baker Hughes Incorporated 19.5. Clariant AG 19.6. Ecolab Inc. 19.7. Evonik Industries AG 19.8. Force Chem Technologies LLC 19.9. Halliburton Co 19.10. GasHydrate LLC 20. Assumptions and Acronyms Used 21. Research Methodology
Explore Chemicals & Materials Insights
View Reports
Low dosage Hydrate Inhibitors Market
